Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313291406> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- W4313291406 endingPage "222" @default.
- W4313291406 startingPage "216" @default.
- W4313291406 abstract "Introduction/Objective. The aim of our study was to retrospectively analyze data about efficacy and persistence on different anti-TNF? treatment in spondyloarthritis (SpA). Methods. We retrospectively analyzed SpA patients whose data were entered into the Serbian national SpA registry. All patients were divided in two groups: non-switcher (patients who were treated with one anti-TNF?) and switcher group (who has switched from first to second and third anti-TNF?). Disease activity was measured by the Ankylosing Spondylitis Disease Score and the Bath Ankylosing Spondylitis Disease Activity Index and functional status was measured by the Bath Ankylosing Spondylitis Functional Index. Results. We identified 290 SpA patients ? 250 patients with axial SpA (axSpA) and 40 patients with peripheral SpA (pSpA). Among 250 patients with axSpA, 192 (76.8%) did not change first anti-TNF?, while 58 (23.2%) switched to the second and 14 (5.6%) switched to the third anti-TNF?. Among 40 patients with pSpA, 29 (72.5%) did not change first anti-TNF? while 11 (27.5%) switched to the second and three (7.5%) switched to the third anti-TNF?. Survival on the first anti-TNF? was 35.16 ? 28.5 months (switchers 29.41 ? 21.89 vs. non-switchers 36.89 ? 30.04). ?t the moment of this cross-section 37 (19.3%) patients still had very high disease activity, while only 75 (39%) patients had inactive disease. Conclusions. In real-life clinical practice in our country, as well as in others, there is reluctance to anti- TNF? switch in SpA patients. Administrative limitations and national reimbursement policy could be one of the main reasons limiting treat to target implementation in SpA patients. Additionally, specific drug efficacy on extra-articular manifestations is often the reason for choosing the first line medication or switching to the next one." @default.
- W4313291406 created "2023-01-06" @default.
- W4313291406 creator A5008183268 @default.
- W4313291406 creator A5022017161 @default.
- W4313291406 creator A5029368921 @default.
- W4313291406 creator A5033651617 @default.
- W4313291406 creator A5036400874 @default.
- W4313291406 creator A5069508163 @default.
- W4313291406 creator A5070820005 @default.
- W4313291406 creator A5074867360 @default.
- W4313291406 creator A5082531103 @default.
- W4313291406 date "2023-01-01" @default.
- W4313291406 modified "2023-09-26" @default.
- W4313291406 title "Persistence on anti-TNF therapy - data from Serbian National Spondyloarthritis Registry" @default.
- W4313291406 cites W1966756689 @default.
- W4313291406 cites W2109172918 @default.
- W4313291406 cites W2120557677 @default.
- W4313291406 cites W2130303906 @default.
- W4313291406 cites W2139351039 @default.
- W4313291406 cites W2155748078 @default.
- W4313291406 cites W2513232504 @default.
- W4313291406 cites W2572897530 @default.
- W4313291406 cites W2793442523 @default.
- W4313291406 cites W2794595980 @default.
- W4313291406 cites W2896581235 @default.
- W4313291406 cites W2902967013 @default.
- W4313291406 cites W2945448760 @default.
- W4313291406 cites W2954986885 @default.
- W4313291406 cites W2961280928 @default.
- W4313291406 cites W2981937824 @default.
- W4313291406 cites W3081045464 @default.
- W4313291406 cites W3089043373 @default.
- W4313291406 cites W3195747507 @default.
- W4313291406 cites W3201191748 @default.
- W4313291406 doi "https://doi.org/10.2298/sarh220319121c" @default.
- W4313291406 hasPublicationYear "2023" @default.
- W4313291406 type Work @default.
- W4313291406 citedByCount "0" @default.
- W4313291406 crossrefType "journal-article" @default.
- W4313291406 hasAuthorship W4313291406A5008183268 @default.
- W4313291406 hasAuthorship W4313291406A5022017161 @default.
- W4313291406 hasAuthorship W4313291406A5029368921 @default.
- W4313291406 hasAuthorship W4313291406A5033651617 @default.
- W4313291406 hasAuthorship W4313291406A5036400874 @default.
- W4313291406 hasAuthorship W4313291406A5069508163 @default.
- W4313291406 hasAuthorship W4313291406A5070820005 @default.
- W4313291406 hasAuthorship W4313291406A5074867360 @default.
- W4313291406 hasAuthorship W4313291406A5082531103 @default.
- W4313291406 hasBestOaLocation W43132914061 @default.
- W4313291406 hasConcept C126322002 @default.
- W4313291406 hasConcept C17991360 @default.
- W4313291406 hasConcept C1862650 @default.
- W4313291406 hasConcept C2777402515 @default.
- W4313291406 hasConcept C2779134260 @default.
- W4313291406 hasConcept C2908564923 @default.
- W4313291406 hasConcept C2909063479 @default.
- W4313291406 hasConcept C71924100 @default.
- W4313291406 hasConceptScore W4313291406C126322002 @default.
- W4313291406 hasConceptScore W4313291406C17991360 @default.
- W4313291406 hasConceptScore W4313291406C1862650 @default.
- W4313291406 hasConceptScore W4313291406C2777402515 @default.
- W4313291406 hasConceptScore W4313291406C2779134260 @default.
- W4313291406 hasConceptScore W4313291406C2908564923 @default.
- W4313291406 hasConceptScore W4313291406C2909063479 @default.
- W4313291406 hasConceptScore W4313291406C71924100 @default.
- W4313291406 hasIssue "3-4" @default.
- W4313291406 hasLocation W43132914061 @default.
- W4313291406 hasOpenAccess W4313291406 @default.
- W4313291406 hasPrimaryLocation W43132914061 @default.
- W4313291406 hasRelatedWork W1980199917 @default.
- W4313291406 hasRelatedWork W2018410379 @default.
- W4313291406 hasRelatedWork W2022537980 @default.
- W4313291406 hasRelatedWork W2072405548 @default.
- W4313291406 hasRelatedWork W2102900383 @default.
- W4313291406 hasRelatedWork W2318568462 @default.
- W4313291406 hasRelatedWork W2353174813 @default.
- W4313291406 hasRelatedWork W3090239339 @default.
- W4313291406 hasRelatedWork W3152003751 @default.
- W4313291406 hasRelatedWork W4247812811 @default.
- W4313291406 hasVolume "151" @default.
- W4313291406 isParatext "false" @default.
- W4313291406 isRetracted "false" @default.
- W4313291406 workType "article" @default.